- Background: Both EPO levels and anemia have shown prognostic value in several cardiac disorders. An observational study with a prospective follow-up was performed to investigate their independent prognostic roles in severe aortic stenosis. Methods: An up to 36-month follow-up of consecutive patients with severe aortic stenosis undergoing TAVR in a high-volume center was performed. Patients with eGRF <30 mL/min/1.73 m2 were excluded. EPO levels and/or anemia status and its association with mid-term mortality were assessed. Results: Out of 407, 360 met eligibility criteria. Median age was 83 years, with 71.4% having a NYHA class III/IV. Anemia was present in 51.9%, and iron deficiency in 52.8%. Median (IQR) EPO levels were 14.4 (9.30–24.30) mIU/mL. Median follow-up was 566 days. Anemia was associated with overall mortality (HR 2.40, 95% CI 1.51–3.80, p < 0.001). Higher logEPO levels were associated with mid-term mortality (HR 4.05, 95% CI 2.29–7.16, p < 0.001), even after adjusting for clinically and/or statistically relevant factors (multivariate HR 2.25, 95 CI 1.09–4.66, p = 0.029). Kaplan-Meier analyses showed early diverging curves for anemia vs. non-anemia, whereas curves for patients in various EPO level quartiles started to diverge at about 100 days, with differences consistently increasing during the subsequent entire follow-up period. Conclusions: Differently from anemia, which was a strong predictor for both early and late mortality in severe aortic stenosis after TAVR, independent prognostic value of EPO only emerged after post-TAVR recovery. EPO prognostic value was independent from anemia and mild-to-moderate renal dysfunction. High EPO levels could be useful to identify patients with severe aortic stenosis showing a compromised mid-term survival in spite of TAVR use and independently from early TAVR results.
MetadatenAuthor: | Silvia Mas-PeiroORCiDGND, Philipp SeppeltORCiDGND, Roberta De RosaORCiD, Marie-Isabel Murray, Jörg Yogarajah, Alexander BerkowitschGND, Stephan Fichtlscherer, Andreas M. ZeiherORCiDGND, Mariuca Vasa-NicoteraORCiDGND |
---|
URN: | urn:nbn:de:hebis:30:3-571971 |
---|
DOI: | https://doi.org/10.3389/fcvm.2020.605257 |
---|
ISSN: | 2297-055X |
---|
Parent Title (English): | Frontiers in Cardiovascular Medicine |
---|
Publisher: | Frontiers Media |
---|
Place of publication: | Lausanne |
---|
Document Type: | Article |
---|
Language: | English |
---|
Date of Publication (online): | 2020/11/30 |
---|
Date of first Publication: | 2020/11/30 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2020/12/17 |
---|
Tag: | anemia; biomarker; erythropoietin (EPO); prognostic value; transcatheter aortic valve replacement (TAVR), aortic valve stenosis (AS) |
---|
Volume: | 7 |
---|
Issue: | article 605257 |
---|
Note: | SM-P has been supported by a Cardiopulmonary Institute (CPI) grant and a German Center for Cardiovascular Research (DZHK) grant. |
---|
HeBIS-PPN: | 477469701 |
---|
Institutes: | Medizin / Medizin |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung 4.0 |
---|